RKVTF (Rakovina Therapeutics) Interest Expense: $-0.32 Mil (TTM As of Mar. 2026)


RKVTF Rakovina Therapeutics Inc RKVTF
27 GF Score
Price $0.09
! 1 Warning Sign
View Full Analysis

What is Rakovina Therapeutics Interest Expense?

Rakovina Therapeutics RKVTF -5.71% 27 Interest Expense is $-0.32 Mil as of Mar. 2026. GuruFocus rates RKVTF with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Rakovina Therapeutics's interest expense for the three months ended in Mar. 2026 was $ -0.07 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.32 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Rakovina Therapeutics's Operating Income for the three months ended in Mar. 2026 was $ -1.08 Mil. Rakovina Therapeutics's Interest Expense for the three months ended in Mar. 2026 was $ -0.07 Mil. Rakovina Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rakovina Therapeutics  (OTCPK:RKVTF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Rakovina Therapeutics's Interest Expense for the three months ended in Mar. 2026 was $-0.07 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-1.08 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $2.19 Mil.

Rakovina Therapeutics's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Rakovina Therapeutics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Rakovina Therapeutics Interest Expense Historical Data

* Premium members only.

The historical data trend for Rakovina Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rakovina Therapeutics Interest Expense Chart

Rakovina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
0.00 0.00 -0.11 -0.19 -0.30

Rakovina Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.07 -0.10 -0.08 -0.07
RKVTF
27GF Score
Rakovina Therapeutics Inc RKVTF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rakovina Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.32 Mil mean?
Rakovina Therapeutics (RKVTF) has a Interest Expense of $-0.32 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Rakovina Therapeutics and its competitors.
Is Rakovina Therapeutics' Interest Expense too high?
Rakovina Therapeutics' current Interest Expense is $-0.32 Mil. Overall, Rakovina Therapeutics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Rakovina Therapeutics' Interest Expense compare to VRTX and REGN?
Rakovina Therapeutics' Interest Expense of $-0.32 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Rakovina Therapeutics and its competitors. Rakovina Therapeutics's current Interest Expense is $-0.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rakovina Therapeutics stock overvalued right now?
Rakovina Therapeutics (RKVTF) has a current Interest Expense of $-0.32 Mil. The current Interest Expense is $-0.32 Mil. Rakovina Therapeutics' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Rakovina Therapeutics (RKVTF), the current Interest Expense is $-0.32 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rakovina Therapeutics Business Description

Other Exchanges 7JO0:GermanyRKV:Canada
Address 999 West Broadway, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
27GF Score

Get the complete analysis for RKVTF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.09
Price